搜索优化
English
搜索
图片
Copilot
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
pharmaphorum
27 分钟
Obesity needs a new definition, says global commission
That is the conclusion of a report by the global Commission on Clinical Obesity – published in The Lancet Diabetes and ...
pharmaphorum
35 分钟
5 strategies to retain top talent
The success of strategies focused on development, change management partnerships, progression flexibility, recognition ...
pharmaphorum
18 小时
Delivery: The key to navigating pharmacy deserts in 2025
Pharmacy numbers dropped from 11,522 in 2022 to 11,414 in 2023, and a further 436 closed this year in 2024. As numbers ...
pharmaphorum
18 小时
JP Morgan Week 2025 - Day 2
On Tuesday we’ll hop on BART to go down to the Hyatt Regency San Francisco for a portion of Fierce JPM Week. Our coverage ...
pharmaphorum
19 小时
Life Sciences Industry Report 2025
In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...
pharmaphorum
21 小时
AIs can be used for fracture detection, says NICE
"Clinical evidence suggests that the AI technologies may improve fracture detection on X‑rays in urgent care without ...
pharmaphorum
22 小时
Grifols gets $21m award for Parkinson's biomarker hunt
Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...
pharmaphorum
23 小时
FDA sets August date for subcutaneous Leqembi decision
To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...
pharmaphorum
23 小时
Bayer gains ground in two-fronted Parkinson's offensive
Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...
pharmaphorum
1 天
Lilly nets Scorpion cancer drug in $2.5bn licensing deal
Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in ...
pharmaphorum
1 天
The intricacies of effectively transitioning active clinical trials to the EU Clinical ...
Over more than eight years of monitoring, getting familiar with the EU CTR, conducting trial submissions activities, etc., ...
pharmaphorum
1 天
How data science and AI will transform life sciences in 2025
And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈